Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
CFI-402411 by Treadwell Therapeutics for Pancreatic Cancer: Likelihood of Approval
CFI-402411 is under clinical development by Treadwell Therapeutics and currently in Phase II for Pancreatic Cancer. According to GlobalData, Phase...
CFI-402411 by Treadwell Therapeutics for Colorectal Cancer: Likelihood of Approval
CFI-402411 is under clinical development by Treadwell Therapeutics and currently in Phase II for Colorectal Cancer. According to GlobalData, Phase...
CFI-402411 by Treadwell Therapeutics for Prostate Cancer: Likelihood of Approval
CFI-402411 is under clinical development by Treadwell Therapeutics and currently in Phase II for Prostate Cancer. According to GlobalData, Phase...